Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has agreed to acquire a 0.85% Gross Revenue Royalty (GRR) over the Phalaborwa rare earth project in South Africa for a total cash consideration of...
Shares in Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) are "cheap", said broker Peel Hunt in a short note following an update on a project over which Ecora has a royalty agreement. Peel pick...
ROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Commercial Off the Shelf...
ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today annou...
The average of price targets set by Wall Street analysts indicates a potential upside of 251.8% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the p...
LONDON, UNITED KINGDOM / ACCESSWIRE / May 20, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 20 May 2024, it purchased 200,000 ordinary shares of 2p each in the Company (the "Shares...
The average of price targets set by Wall Street analysts indicates a potential upside of 215.9% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the p...
electroCore, Inc. (NASDAQ:ECOR ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Dan Goldberger - CEO Brian Posner - CFO Conference Call Participants Jeffrey Cohen - Laden...
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $1.24 per share a year ago....
Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023 Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST...
ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2...